Frontline therapy for multiple myeloma:a concise review of the evidence based on randomized clinical trials[J]. Cancer Invest, 2013,31(8):529-537. DOI: 10.3109/07357907.2013.840382 . 返回引文位置Google Scholar 百度学术 万方数据 [18] 康岩,赵月莹,郭梅,等. 硼替佐米治疗伴有肾脏损害的多发性骨髓...
Frontline therapy for multiple myeloma:a concise review of the evidence based on randomized clinical trials[J]. Cancer Invest, 2013,31(8):529-537. DOI: 10.3109/07357907.2013.840382 . 返回引文位置Google Scholar 百度学术 万方数据 [2] Palumbo A , Cavallo F , Gay F ,et al. Autologous ...
:1·495· 2.2对肾功能的影响 本研究BDT方案组较改良VAD方案组起效快,缓解率 BDT方案组中3例治疗前伴有肾功能损害的患者,治疗后 高,总有效率达92.3%。BDT方案组患者的主要不良反应为周 均有明显改善,其中2例尿毒症患者经2个疗程化疗后未行血 围神经病变,发生率为54%,多为指尖麻木,无一例因严重周 液透析...
DVd Superior to Vd Regardless of Prior Lines of Therapy in MyelomaJason HoffmanPharmD
Induction Therapy and Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma Autologous stem cell transplantation (ASCT) is considered the standard therapy for younger patients with newly diagnosed symptomatic multiple myeloma (MM)... R Ria,A Reale,AG Solimando,... - 《Stem Cells...
“For over 1 ½ years I had continuously dealt with this pain. It caused me to limit bodywork to one session a day, to get sometimes daily chiro adjustments, and use the laser therapy at the office several times a week. The only medical option given to me was to give up bodywork. ...
EMA Review of Daratumumab for the Treatment of Adult Patients with Multiple Myeloma and dexamethasone, or bortezomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. ... K Tzogani,E Penninga,ML Schougaard Christiansen,......
Methods: All pts received ≥1 prior line of therapy (LOT) and were administered 8 cycles (Q3W) of Vd (1.3 mg/m 2 SC bortezomib on days 1, 4, 8, and 11; 20 mg PO/IV dexamethasone on days 1-2, 4-5, 8-9, and 11-12) ± D (16 mg/kg IV once weekly in Cycles 1-3, ...
1 to evaluate different coagulationparameters, from there on R was started on day 1 of therapy.The regimen was given as follows: on day 1 D was given at 40mg/mIVPB; V at 2 mg IVP; d at 40 mg PO daily X 4 days; R wasstarted at 5 mg a day for 21 days with one week off. ...